Moneycontrol PRO
HomeAuthorAshwin mohan

Ashwin Mohan

Deputy Editor - Deals

Moneycontrol

Tata vs Mistry: Shapoorji Pallonji Group looks to part ways with Tatas

BUSINESS

Tata vs Mistry: Shapoorji Pallonji Group looks to part ways with Tatas

Separation from Tata Group is necessary to protect interest of stakeholders, says Shapoorji Pallonji Group.

Why is 2020 emerging as ‘spiciest’ year ever for Indian M&A?

BUSINESS

Why is 2020 emerging as ‘spiciest’ year ever for Indian M&A?

For centuries, the spice trade has had a whiff of romance about it. In 2020, it also seems to be making good business sense, with plenty of lip-smacking deals.

Exclusive | Spice maker Badshah Masala completes internal rejig as promoters part ways

BUSINESS

Exclusive | Spice maker Badshah Masala completes internal rejig as promoters part ways

Hemant Jhaveri acquires 24 percent stake held by Kailash Jhaveri. The Badshah Masala stake sale is the third successive M&A deal in the domestic branded spices segment in 2020 after the twin buyouts of Sunrise Foods by ITC and Eastern Condiments by Norway’s Orkla through its arm MTR Foods

BVG India plans IPO; pure-play facility management leader targets up to Rs 1,300 crore

BUSINESS

BVG India plans IPO; pure-play facility management leader targets up to Rs 1,300 crore

The Pune-based firm counts Indian Railways, Rashtrapati Bhavan, the Tata Group, Hindustan Unilever and Accenture as its clients.

Promoters of Hyderabad-based Granules India revive exit plans

BUSINESS

Promoters of Hyderabad-based Granules India revive exit plans

Recent deals like Advent-Ra Chem Pharma, Carlyle – Sequent Scientific and Carlyle –Piramal Enterprises are examples of rising interest from private equity funds in the domestic active pharmaceutical ingredients segment.

Indiabulls Housing Finance launches QIP with base size of $60 million, floor price of Rs 206.7/share

BUSINESS

Indiabulls Housing Finance launches QIP with base size of $60 million, floor price of Rs 206.7/share

The QIP launch follows the trend of many banks and NBFCs hitting the market to raise funds to soften the hit of potential bad loans triggered by the COVID-19 pandemic

Amber Enterprises launches QIP to raise around Rs 400 crore

BUSINESS

Amber Enterprises launches QIP to raise around Rs 400 crore

Moneycontrol was the first to report on the firm’s QIP plans on August 22 and had indicated that the launch was likely in September

Ekta Kapoor on challenges for streaming peer Netflix, Direct OTT release controversy and content regulation

BUSINESS

Ekta Kapoor on challenges for streaming peer Netflix, Direct OTT release controversy and content regulation

Ekta Kapoor speaks no holds barred on self-censorship, OTT releases and what's in store for future for Balaji Telefilms.

Open to strategic or financial partner who can see value in business, says Ekta Kapoor

BUSINESS

Open to strategic or financial partner who can see value in business, says Ekta Kapoor

Our main game in the next five years is to grow market, says joint Managing Director of Balaji Telefilms.

Edelweiss, Deloitte selected as pre-IPO advisors for largest-ever LIC IPO

BUSINESS

Edelweiss, Deloitte selected as pre-IPO advisors for largest-ever LIC IPO

The scope of the mandate includes advising the Centre on the modalities of the IPO and the timing, and arriving at an optimal capital structure.

‘Kyunki digital ka zamana hain’: Ekta Kapoor’s Balaji Telefilms begins search for investors

BUSINESS

‘Kyunki digital ka zamana hain’: Ekta Kapoor’s Balaji Telefilms begins search for investors

Balaji Telefilms, one of India’s most successful production houses, is targeting strategic and financial opportunities to add value to its business, especially the fast growing OTT vertical

Serum Institute exploring fund raise at subsidiary level by diluting minority stake for COVID-19 project: Adar Poonawalla

BUSINESS

Serum Institute exploring fund raise at subsidiary level by diluting minority stake for COVID-19 project: Adar Poonawalla

The fund raising plans are at an early stage and were confirmed by Serum Institute CEO Adar Poonawalla

HDFC appoints record 19 merchant banks for mega Rs 14,000-crore fund raise

BUSINESS

HDFC appoints record 19 merchant banks for mega Rs 14,000-crore fund raise

This is arguably the biggest consortium of merchant bankers/advisors ever taken on board by an Indian corporate for fundraising purposes in the equity capital markets and sets a new record for India Inc.

PTC India puts majority stake in NBFC arm PTC India Financial Services on the block

BUSINESS

PTC India puts majority stake in NBFC arm PTC India Financial Services on the block

The board of PTC India had initially proposed the divestment plans to shareholders on August 7, 2019 but received the requisite internal approvals for the deal after delays on account of the ongoing COVID-19 pandemic

RIL AGM: The largest continuous fundraising by a corporate has ended. Or has it?

BUSINESS

RIL AGM: The largest continuous fundraising by a corporate has ended. Or has it?

In less than four months, Jio Platforms has attracted a staggering Rs 152,056 crore from a total of 13 investors by shedding around 33 percent stake

China’s Fosun-backed Gland Pharma files papers for Rs 5,000-6,000 crore IPO

BUSINESS

China’s Fosun-backed Gland Pharma files papers for Rs 5,000-6,000 crore IPO

If the listing plans fructify, this could arguably be the first major domestic IPO of an Indian company with a Chinese parent.

Info Edge lines up 4 merchant bankers for QIP

BUSINESS

Info Edge lines up 4 merchant bankers for QIP

Consumer internet company Info Edge, which backs the likes of Naukri.com, 99acres.com and Zomato, Aims to build COVID -19 M&A warchest

Rossari Biotech IPO to open on July 13; price band of Rs 423-425 per share

BUSINESS

Rossari Biotech IPO to open on July 13; price band of Rs 423-425 per share

On July 3, 2020, Moneycontrol had reported that the Rossari Biotech is all set to be the first listed company in the lockdown phase.

Exclusive | Hedge fund Route One Investment in talks to raise stake in IndusInd Bank

BUSINESS

Exclusive | Hedge fund Route One Investment in talks to raise stake in IndusInd Bank

A few other investors may also join Route One and participate in what could potentially be a wider fundraising round through the preferential allotment route

Exclusive | Rossari Biotech to end IPO hiatus, likely to be first listed company in COVID-19 lockdown

BUSINESS

Exclusive | Rossari Biotech to end IPO hiatus, likely to be first listed company in COVID-19 lockdown

It has been 108 days since an Indian company made its debut on Dalal Street.

Exclusive | Ex-ICICI Bank executive Murali Ramakrishnan likely to be named as CEO of South Indian Bank

BUSINESS

Exclusive | Ex-ICICI Bank executive Murali Ramakrishnan likely to be named as CEO of South Indian Bank

If the proposed move fructifies, Ramakrishnan would be the first MD & CEO of South Indian Bank coming on board from a private sector lender.

Yes Bank takes Zee Entertainment to court over $50 million loan guarantee spat

BUSINESS

Yes Bank takes Zee Entertainment to court over $50 million loan guarantee spat

Yes Bank fails to get interim relief in the Bombay High Court, case is related to a disputed guarantee on a 2016 loan.

Contract research firm Anthem Biosciences looks to sell minority stake in deal valuing firm at $1 billion

BUSINESS

Contract research firm Anthem Biosciences looks to sell minority stake in deal valuing firm at $1 billion

“Anthem Biosciences is looking to tap investors, primarily private equity funds & sell a 10 percent stake in the firm and raise around $100 million. If plans fructify, this would value the firm at a billion dollars," a source said.

Private equity firm Carlyle to buy a fifth of Piramal Ent's pharma business for nearly $490 million

BUSINESS

Private equity firm Carlyle to buy a fifth of Piramal Ent's pharma business for nearly $490 million

The transaction values the Piramal Pharma at an enterprise value (EV) of $2.77 billion with an upside component of up to $360 million depending on the company’s FY21 performance.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347